FRM
RVNC

Fox Run Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Fox Run Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18,360
Closed -$211K – 1072
2023
Q3 		$211K Buy
+18,360
New +$211K 0.06% 545
2018
Q3 		– Sell
-18,477
Closed -$507K – 869
2018
Q2 		$507K Buy
+18,477
New +$507K 0.16% 242